pharmacie et médicaments – Remboursement par l'assurance maladie des médicaments contre l'obésité

This written question asks about the conditions and procedures for reimbursing obesity medications by the national health insurance system. It seeks clarification on the current policies and potential future changes regarding access to these treatments. The question concerns patients seeking treatment for obesity, healthcare providers, and the national health insurance fund. It aims to ensure clarity and potentially improve access to necessary medications for those affected by obesity.